Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCTR20140806001Phase 3Completed
A Phase 3 trial of sulodexide in type 2 diabetes mellitus (T2DM), diabetic glomerulosclerosis, sponsored by Phramongkutklao Hospital and College of Medicine. Started Aug 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on TCTR20140806001.